Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
100M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
261K
-
Shares change
-
+61.4K
-
Total reported value, excl. options
-
$177K
-
Value change
-
-$26.9K
-
Number of buys
-
8
-
Number of sells
-
-2
-
Price
-
$0.68
Significant Holders of PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) as of Q1 2025
12 filings reported holding PALI - PALISADE BIO, INC. - Common Stock, par value $0.01 per share as of Q1 2025.
PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 261K shares
of 100M outstanding shares and own 0.26% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (145K shares), UBS Group AG (38.1K shares), GEODE CAPITAL MANAGEMENT, LLC (24.7K shares), HRT FINANCIAL LP (18.3K shares), Virtu Financial LLC (15.3K shares), TWO SIGMA SECURITIES, LLC (14.2K shares), Tower Research Capital LLC (TRC) (4.57K shares), MORGAN STANLEY (628 shares), Federation des caisses Desjardins du Quebec (100 shares), and BANK OF AMERICA CORP /DE/ (23 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.